Evolution of monoclonal gammopathy of undetermined significance in patients treated with JAK inhibitors for rheumatic diseases: data from the MAJIK-SFR registry

Monoclonal gammopathy of undetermined significance (MGUS) is common, but there are scarce data regarding the effect of DMARDs on this premalignant condition. We aimed to evaluate the impact of JAK inhibitors (JAKis) on MGUS when initiated for an active rheumatic disease. Patients with monoclonal abn...

Full description

Bibliographic Details

Published in:	Rheumatology (Oxford, England) Vol. 63; no. 3; p. 787
Main Authors:	Faganello, Déborah, Bertrand, Anne, Meunier, Pauline, Avouac, Jérôme, Toussirot, Eric, Coury, Fabienne, Seror, Raphaele, Le Mélédo, Guillaume, Germain, Vincent, Dellal, Azedinne, Shima, Ditmar, Hulin, Cyrille, Prati, Clément, Schaeverbeke, Thierry, Richez, Christophe, Truchetet, Marie-Elise, Kostine, Marie
Format:	Journal Article
Language:	English
Published:	England 01-03-2024
Subjects:	Aged Antibodies, Monoclonal Arthritis, Psoriatic Humans Immunoglobulin G Janus Kinase Inhibitors - therapeutic use Monoclonal Gammopathy of Undetermined Significance - drug therapy Prospective Studies Rheumatic Diseases - drug therapy monoclonal gammopathy of undetermined significance myeloma rheumatic diseases JAK inhibitors RA
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!